INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 112 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $139,000 | -24.0% | 15,622 | +0.5% | 0.00% | -71.4% |
| Q3 2016 | $183,000 | -36.0% | 15,543 | -29.8% | 0.01% | -53.3% |
| Q2 2016 | $286,000 | -87.3% | 22,144 | -71.8% | 0.02% | -91.4% |
| Q4 2015 | $2,246,000 | +462.9% | 78,444 | +460.0% | 0.17% | +176.2% |
| Q3 2015 | $399,000 | -89.8% | 14,009 | -87.2% | 0.06% | -59.9% |
| Q2 2015 | $3,929,000 | +20.0% | 109,364 | +94.1% | 0.16% | +19.8% |
| Q1 2015 | $3,275,000 | – | 56,345 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 788,175 | $10,199,000 | 4.68% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,987,313 | $116,296,000 | 2.40% |
| Antipodean Advisors LLC | 305,294 | $3,951,000 | 2.39% |
| Freshford Capital Management, LLC | 475,984 | $6,159,000 | 1.81% |
| Folger Hill Asset Management LP | 1,597,945 | $20,677,000 | 1.61% |
| JW Asset Management, LLC | 150,638 | $1,949,000 | 1.55% |
| 12 West Capital Management LP | 623,791 | $8,072,000 | 1.30% |
| Orbimed Advisors | 4,688,240 | $60,666,000 | 0.63% |
| CYPRESS FUNDS LLC | 135,584 | $1,754,000 | 0.41% |
| Rock Springs Capital Management LP | 365,500 | $4,730,000 | 0.35% |